+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Uvadex"

From
  • 1 Results (Page 1 of 1)
Loading Indicator

Uvadex is a brand of lymphoma drugs used to treat certain types of non-Hodgkin's lymphoma. It is a type of chemotherapy drug that works by targeting and killing cancer cells. Uvadex is a liposomal formulation of the chemotherapy drug, doxorubicin, which is encapsulated in tiny fat particles. This allows the drug to be delivered directly to the cancer cells, reducing the risk of side effects. Uvadex is used in combination with other chemotherapy drugs to treat certain types of non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma. The Uvadex market is a rapidly growing segment of the global pharmaceutical industry. It is driven by the increasing prevalence of non-Hodgkin's lymphoma, as well as the need for more effective treatments. Companies in the Uvadex market include Merck, Pfizer, and Bristol-Myers Squibb. Other companies in the market include Celgene, Novartis, and AstraZeneca. Show Less Read more